Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Closed: May 26, 03:10 AM 2012  
FNMFO KDDIF 096770 AMKBF CTGBZ AU 
 
 
  NYSE  7,534  18.032  Index Moved Down 



Processing
Collecting data for EMIS and NKTR ...

Asset Comparison and Correlation

    
       
Investment horizon: 
30 Days (Login to change)
       
 
    
 Emisphere Technologies Inc.  and   Nektar Therapeutics
Check Correlation Matrix  
Daily Returns (%)
NKTR  EMIS  
Timeline
Assuming 30 trading days horizon, Emisphere Technologies Inc. is expected to generate 3.4 times more return on investment than Nektar. However, Emisphere is 3.4 times more volatile than Nektar Therapeutics. It trades about -0.05 of its potential returns per unit of risk. Nektar Therapeutics is currently generating about -0.17 per unit of risk. If you would invest 20.00 in Emisphere Technologies Inc. on April 26, 2012 and sell it today you would earn a total of 3.00 from holding Emisphere Technologies Inc. or generate 15.0% return on investment over 30 days.

Diversification

Good diversification
Overlapping area represents amount of risk that can be diversified away by holding Emisphere Technologies Inc. and Nektar Therapeutics in the same portfolio (assuming nothing else is changed)

Correlation Coefficient

-0.17
 Parameters
Time Period1 Month [change]
DirectionNegative EMIS.OB Moved Down vs NKTR
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns
    
Follow Correlation between EMIS and NKTR with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add Correlation between EMIS and NKTR to your reader
 
Get social with Correlation between EMIS and NKTR
 Share Correlation between EMIS and NKTR 
Share Share Correlation between EMIS and NKTR
    
    
 
       
Predicted Return Density
Expected Daily Returns   
NKTR  EMIS  

Emisphere Technologies Inc.

 
    
    
Emisphere
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Emisphere Technologies Inc. has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    
Amgen Inc. vs. Emisphere Technologies Inc.
Gilead Sciences Inc. vs. Emisphere Technologies Inc.
Biogen Idec Inc. vs. Emisphere Technologies Inc.
Celgene Corporation vs. Emisphere Technologies Inc.
Alexion Pharmaceuticals Inc. vs. Emisphere Technologies Inc.
Vertex Pharmaceuticals Incorporated vs. Emisphere Technologies Inc.
  

Nektar Therapeutics

 
    
    
Nektar
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days Nektar Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions.
    
    
Amgen Inc. vs. Nektar Therapeutics
Gilead Sciences Inc. vs. Nektar Therapeutics
Biogen Idec Inc. vs. Nektar Therapeutics
Celgene Corporation vs. Nektar Therapeutics
Alexion Pharmaceuticals Inc. vs. Nektar Therapeutics
Vertex Pharmaceuticals Incorporated vs. Nektar Therapeutics
       


 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting